Protamine dosing and its impact in cardiac surgery transfusion practice—A retrospective bi‐institutional analysis
Transfusion · 2024-03 · 64 (3) · 467-474
DOI: 10.1111/trf.17730 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, online erschienen am 24.01.2024. Verfasst von Samhati Mondal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Cardiothoracic Division, University of Maryland School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Thoracic Surgery, Cardiac Surgical Procedures. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
Bleeding after cardiac surgery is common and continues to require 10–20% of the national blood supply. Transfusion of allogeneic blood is associated with increased morbidity and mortality. Excessive protamine in the absence of circulating heparin after weaning off CPB can cause anticoagulation and precipitate bleeding. Hence, adequate dose calculation of protamine is crucial yet under evaluated. Study Design Retrospective cohort study.
Methods
We conducted a retrospective bi‐institutional analysis of cardiac surgical patients who underwent cardiopulmonary bypass (CPB)‐assisted cardiac surgery to assess the impact of protamine dosing in transfusion practice. Total 762 patients were identified from two institutions using electronic medical records and the Society of Thoracic Surgery (STS) database who underwent cardiac surgery using CPB. Patients were similar in demographics and other baseline characteristics. We divided patients into two groups based on mg of protamine administered to neutralize each 100 U of unfractionated heparin (UFH)—low‐ratio group (Protamine: UFH ≤ 0.8) and high‐ratio group (Protamine: UFH > 0.8).
Results
We observed a higher rate of blood transfusion required in high‐ratio group (ratio >0.8) compared with low‐ratio group (ratio ≤0.8) ( p < .001). The increased requirement was consistently demonstrated for intraoperative transfusions of red blood cells, plasma, platelets, and cryoprecipitate.
Conclusion
High protamine to heparin ratio may cause increased bleeding and transfusion in cardiac surgical patients. Protamine to heparin ratio of 0.8 or lower is sufficient to neutralize circulating heparin after weaning off cardiopulmonary bypass.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Cardiothoracic Division, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Department of Anesthesiology, Cardiothoracic Division, University of Pittsburgh School of Medicine and UPMC, Pennsylvania, USA.
- Department of Epidemiology and Public Health, Biostatistics Division; Department of Anesthesiology, National Study Center, University of Maryland, Baltimore, Maryland, USA.
- Department of Anesthesiology, WakeMed Health System, Raleigh, North Carolina, USA.
- Department of Anesthesiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
ORCID-Profile: Samhati Mondal, Kenichi A Tanaka
Zitieren
APA
Mondal, S., Abuelkasem, E., Vesselinov, R., Henderson, R., Choi, S., Mousa, A., Zaza, K. J., & Tanaka, K. A. (2024). Protamine dosing and its impact in cardiac surgery transfusion practice—A retrospective bi‐institutional analysis. Transfusion, 64(3), 467-474. https://doi.org/10.1111/trf.17730
Vancouver
Mondal S, Abuelkasem E, Vesselinov R, Henderson R, Choi S, Mousa A, et al. Protamine dosing and its impact in cardiac surgery transfusion practice—A retrospective bi‐institutional analysis. Transfusion. 2024;64(3):467-474. doi:10.1111/trf.17730
BibTeX
@article{Mondal2024,
author = {Mondal, Samhati and Abuelkasem, Ezeldeen and Vesselinov, Roumen and Henderson, Reney and Choi, Seung and Mousa, Ahmad and Zaza, Khaled J and Tanaka, Kenichi A},
title = {Protamine dosing and its impact in cardiac surgery transfusion practice—A retrospective bi‐institutional analysis},
journal = {Transfusion},
year = {2024},
volume = {64},
number = {3},
pages = {467--474},
doi = {10.1111/trf.17730}
}
EUVIMED